Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M94.5Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-2.2
Enterprise Value $M22.9EPS (TTM) $-3.5Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.7Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio9.9Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-4.5Current Ratio9.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-68.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M22.6ROIC % (ttm)-258.9Gross Margin Increase y-yN

Gurus Latest Trades with CASC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CASC is held by these investors:



CASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOVE TED WDirector 2017-02-02Buy23,000$4.24-2.83view
HENNEY CHRISTOPHER SDirector 2017-01-30Buy25,324$4.110.24view
Myers Scott DunsethPresident and CEO 2017-01-27Buy20,500$3.769.57view
Myers Scott DunsethPresident and CEO 2016-08-17Buy7,500$6.9-40.29view
Myers Scott DunsethPresident and CEO 2016-06-28Buy10,417$4.8-14.17view
HAUSMAN DIANAChief Medical Officer 2015-06-01Buy5,747$4.65-11.4view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61155.9view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61155.9view
BVF PARTNERS L P/IL10% Owner 2014-12-12Sell0$0155.9view
Venkatesan JayEVP and General Manager 2014-09-23Buy250,000$2106view

Quarterly/Annual Reports about CASC:

    News about CASC:

    Articles On GuruFocus.com
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics Jul 11 2016 
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 

    More From Other Websites
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement Feb 03 2017
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jan 27 2017
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 24 2017
    Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings of Common Stock and Preferred Stock Jan 24 2017
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jan 23 2017
    Cascadian Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred... Jan 23 2017
    Cascadian Therapeutics Announces 2017 Outlook and Recent Drug Portfolio Progress Jan 05 2017
    Cascadian Therapeutics Announces 2017 Outlook and Recent Drug Portfolio Progress Jan 05 2017
    Cascadian Therapeutics Appoints Dr. Marc L. Lesnick as Senior Vice President, Regulatory Affairs and... Jan 04 2017
    Cascadian Therapeutics Appoints Dr. Marc L. Lesnick as Senior Vice President, Regulatory Affairs and... Jan 04 2017
    Should You Buy Alico, Inc. (ALCO)? Dec 20 2016
    Here’s What Smart Money Think about Jones Energy Inc (JONE) Dec 12 2016
    Do Hedge Funds Love Invuity, Inc. (IVTY)? Dec 10 2016
    Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc... Dec 08 2016
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 07 2016
    Cascadian Therapeutics Amends HER2CLIMB Phase 2 Trial of Tucatinib in Metastatic HER2-Positive... Dec 07 2016
    Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards Dec 07 2016
    Cascadian Therapeutics, Inc. :CASC-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 Dec 01 2016
    Cascadian Therapeutics Strengthens Management Team with Key Hires, Monique M. Greer and Marc C.... Nov 28 2016
    Cascadian Therapeutics Announces Stockholders and Board of Directors Approve Reverse Stock Split Nov 23 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)